Premium
Prognostic factors in metastatic germ‐cell cancer
Author(s) -
Beyer J.
Publication year - 2019
Publication title -
andrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.947
H-Index - 43
eISSN - 2047-2927
pISSN - 2047-2919
DOI - 10.1111/andr.12615
Subject(s) - germ cell tumors , germ cell , stage (stratigraphy) , cancer , oncology , disease , biology , clinical trial , metastasis , medicine , bioinformatics , chemotherapy , genetics , paleontology , gene
Determining stage and anticipating prognosis are the two crucial steps after the diagnosis of a germ‐cell cancer that both guide subsequent treatment decisions. This review focuses on metastatic disease, which means germ‐cell cancers beyond stage I limited to the testis. In the past, major centers developed separate staging and prognostic classifications for metastatic germ‐cell cancer, which heavily impaired communication and comparisons across clinical trials. More recently, the classification system of the International Germ‐Cell Cancer Collaborative Group ( IGCCCG ) has found acceptance worldwide and is currently being updated.